India's CDSCO has warned pharma firms against promoting prescription weight-loss drugs (GLP-1s) via surrogate or digital ads, ...

Discover how Dr. Erica Yalavarthi's pioneering wellness center is transforming patient care with a focus on prevention and longevity. Could a longer, healthier life be within your reach?

Weight loss is rarely about one missed tray. It usually reflects breakdowns in workflow, observation, communication, and follow-through. If the interventions exist only on paper, resident decline will ...

GLP-1 drugs like Ozempic have long helped people eat less — now, they’re showing promise in helping people crave less.

Drugs like Wegovy and Zepbound have been hailed as miracle treatments. But one in 10 people are what scientists call ...

A multibagger stock is one that has doubled your money or more. Peter Lynch, the highly respected investment manager who ran the Magellan Fund for 14 years, coined the term in his book, One Up on Wall ...

Cancer cachexia impacts almost 90% of people living with pancreatic cancer. Learn more about this condition in this Q&A with Nicolas Clifford, PanCAN’s manager of research and education communication.

Barclays 28th Annual Global Healthcare Conference March 11, 2026 2:00 PM EDTCompany ParticipantsAdam Steensberg - President ...

Millions of people in the U.S. have sleep apnea, most of whom aren’t getting treated for it. But a simple daily pill of an ...

Hims & Hers Health, Inc.'s revenue is projected to reach $2.7B in 2026 & $3.2B in 2027, implying less than 2x forward sales. Read more on HIMS stock here.

Rochester, Minn.-based Mayo Clinic has developed a minimally invasive procedure that, when combined with endoscopic sleeve gastroplasty, may approach the weight loss of surgical sleeve gastrectomy.